Search research articles
Contact Us
Filters
Showing results (261-270 of 266) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 266 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 6, 2022
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
Tara L Wenger, Sheila Ganti, Catherine Bull, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptor
E K Dziadulewicz, T J Ritchie, A Hallett, et al.
British Journal of Pharmacology
|
February 29, 2000
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
G M Burgess, M N Perkins, H P Rang, et al.
Ebiomedicine
|
September 18, 2024
Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia
Weronika E Borek, Luis Nobre, S Federico Pedicona, et al.
Journal of Medicinal Chemistry
|
May 17, 2002
Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists
Edward K Dziadulewicz, Timothy J Ritchie, Allan Hallett, et al.
Science (New York, N.Y.)
|
June 6, 1998
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
D G Wang, J B Fan, C J Siao, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 266) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 266 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 6, 2022
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
Tara L Wenger, Sheila Ganti, Catherine Bull, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptor
E K Dziadulewicz, T J Ritchie, A Hallett, et al.
British Journal of Pharmacology
|
February 29, 2000
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
G M Burgess, M N Perkins, H P Rang, et al.
Ebiomedicine
|
September 18, 2024
Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia
Weronika E Borek, Luis Nobre, S Federico Pedicona, et al.
Journal of Medicinal Chemistry
|
May 17, 2002
Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists
Edward K Dziadulewicz, Timothy J Ritchie, Allan Hallett, et al.
Science (New York, N.Y.)
|
June 6, 1998
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
D G Wang, J B Fan, C J Siao, et al.
Page
of 27